Clinical Trials Directory

Trials / Completed

CompletedNCT02874443

The REDUCED Trial: REDucing the Utilization of CEsarean Sections for Dystocia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88,918 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This project is a clustered randomized controlled trial of a knowledge translation intervention of new ACOG guidelines for the diagnosis of poor progress in labor. The intent is to reduce the rate of cesarean section (CS) in first time mothers at term (\>= 37 weeks), with a vertex presenting singleton fetus, without increasing maternal or neonatal morbidity. The guidelines were developed from data from the Consortium for Safe Labor. The unit of randomization will be sites in Alberta that deliver

Detailed description

Cluster randomized controlled trial of a knowledge translation intervention of new guidelines for the diagnosis of poor progress in labor. The intervention will be randomized to centres (the clusters) in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually, with stratification based on facility type and geographic location. Clustering by centre and not individual caregivers (nurses/physicians) is necessary to prevent leakage or crossover of the intervention to controls. As all participating centres will eventually receive the intervention, the biostatistician will generate a randomization into two "waves". The intervention will be introduced sequentially by strata (Calgary, Edmonton, regional centres, rural centres) to the first "wave" hospitals in multi-week run-in periods after which those strata will be revisited for roll-out to the second "wave" hospitals.

Conditions

Interventions

TypeNameDescription
OTHERKnowledge Translation of labor management guidelines

Timeline

Start date
2016-10-01
Primary completion
2020-02-28
Completion
2020-03-30
First posted
2016-08-22
Last updated
2025-12-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02874443. Inclusion in this directory is not an endorsement.